welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Thetis Pharmaceuticals Awarded Key Patent on HEALER Technology
Thetis Pharmaceuticals LLC, a privately-held biopharmaceutical company focused on gastrointestinal and cardiometabolic diseases, announced today that the USPTO has granted patent US 9,242,008 providing composition of matter protection for two Thetis development candidates, TP-252 for familial adenomatous polyposis and TP-452 for dyslipidemia. The allowed claims include pharmaceutical compositions that are mineral amino-acid based derivatives of fatty acids. National filings outside of the United States are underway.
expertly curated content related to this topic
-
Familial Adenomatous Polyposis – Genetics Home ReferenceFamilial Adenomatous Polyposis (FAP) is ...
-
Feza H. Remzi, MDDr. Feza Remzi is a gastroenterologist i...
-
Rofecoxib Reduces Polyp Recurrence in Familial Polyposis.The long-term (mean of 16.4 +/- 4.2 mont...
-
Does a Selective Cyclooxygenase-2 Inhibitor (Tiracoxib) Induce Clinically Sufficient Suppression of Adenomas in Pati...BACKGROUND : There have been few placebo...
-
whimsy the blue cancer fairyOn the 27th of February 2015 aged 19 I h...
-
Pharmacological and Dietary Prevention for Colorectal CancerBACKGROUND: Colorectal cancer (CRC) is ...
-
Rachael Brandt, BS, MS, PhDRachael Brandt is a certified genetic co...